Patent Assignment
Reel/Frame 072309/0932
Security Interest
Recorded: 2025-08-01
Pages: 37
Assignors
MYRIAD GENETICS, INC.
Executed: 2025-07-31
MYRIAD GENETIC LABORATORIES, INC.
Executed: 2025-07-31
MYRIAD WOMEN’S HEALTH, INC.
Executed: 2025-07-31
ASSUREX HEALTH, INC.
Executed: 2025-07-31
GATEWAY GENOMICS, LLC
Executed: 2025-07-31
Assignee
ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT FOR SECURED PARTIES
601 LEXINGTON AVENUE, 54TH FLOOR, C/O ORBIMED ADVISORS LLC, NEW YORK, NEW YORK, 10022
Covered Properties
(138)
Noninvasive Prenatal Diagnostic Methods
Detecting Cancer Risk
Patent:
12,637,716 →
Application:
15/996,157 →
Methods and Materials for Assessing Homologous Recombination Deficiency
Systems and Methods for Automatically Generating Genetic Risk Assessments
Application:
16/523,644 →
Publication:
US US20200034761A1
Cancer Biomarkers
Application:
16/664,216 →
Publication:
US US20200056246A1
Methods and Materials for Assessing Loss of Heterozygosity
Method For Determining Genotypes in Regions of High Homology
Application:
16/944,048 →
Publication:
US US20210012859A1
Variant Calling Using Machine Learning
Application:
17/028,303 →
Publication:
US US20210005280A1
Deep Learning Based Variant Calling Using Machine Learning
Gene Signatures for Cancer Prognosis
Application:
17/096,755 →
Publication:
US US20210071269A1
Copy Number Variant Caller
Application:
17/111,272 →
Publication:
US US20210246493A1
Method for Detecting Genetic Variation in Highly Homologous Sequences by Independent Alignment and Pairing of Sequence Reads
Application:
17/158,978 →
Publication:
US US20210225456A1
Methods and Compositions for Enrichment of Target Polynucleotides
Methods and Systems for Somatic Mutations and Uses Thereof
Application:
17/313,946 →
Publication:
US US20210262016A1
Methods and Materials for Assessing Homologous Recombination Deficiency
Application:
17/353,279 →
Publication:
US US20210310079A1
Hereditary Cancer Genes
Detecting Cancer Risk
Methods and Materials for Assessing Loss of Heterozygosity
Application:
17/499,284 →
Publication:
US US20220205046A1
Methods and Materials for Assessing Allelic Imbalance
Application:
17/545,611 →
Publication:
US US20220205022A1
Copy Number Variant Caller
System and Methods for Detecting Genetic Variation
Application:
17/583,035 →
Publication:
US US20220254443A1
Method for Detecting Genetic Variation in Highly Homologous Sequences by Independent Alignment and Pairing of Sequence Reads
Application:
17/630,385 →
Publication:
US US20220284985A1
Gene Signatures for Cancer Prognosis
Application:
17/678,357 →
Publication:
US US20220259675A1
Methods for Identifying Carrier Status and Assessing Risk for Spinal Muscular Atrophy
Application:
17/694,443 →
Publication:
US US20220267837A1
Enrichment of Cell-Free Dna from a Biological Sample
Application:
17/716,381 →
Publication:
US US20220396785A1
Methods and Compositions for Enrichment of Target Polynucleotides
Comprehensive Polygenic Risk Prediction for Breast Cancer
Application:
17/920,012 →
Publication:
US US20230170045A1
Polygenic Trait Prediction Using Local Ancestry
Application:
17/920,013 →
Publication:
US US20230260658A1
Nucleic Acid Sample Enrichment and Screening Methods
Application:
17/926,566 →
Publication:
US US20230193247A1
Bayesian Sex Caller
Application:
18/020,416 →
Publication:
US US20240038339A1
Signatures for Predicting Cancer Immune Therapy Response
Application:
18/072,520 →
Publication:
US US20230094830A1
Methods and Materials for Assessing Homologous Recombination Deficiency in Breast Cancer Subtypes
Application:
18/076,279 →
Publication:
US US20230212653A1
Methods and Materials for Assessing Loss of Heterozygosity
Non-Invasive Prenatal Sample Preparation and Related Methods and Uses
Application:
18/095,386 →
Publication:
US US20230220448A1
Nucleic Acid Sequencing Adapters and Uses Thereof
Methods, Compositions, and Devices for the Rapid Determination of Fetal Sex
Application:
18/257,092 →
Publication:
US US20240018585A1
Global Polygenic Risk Assessment for Breast Cancer
Application:
18/277,554 →
Publication:
US US20240301500A1
Methods, Compositions, and Kits for the Preservation of Nucleic Acids
Application:
18/292,321 →
Publication:
US US20240215569A1
Methods and Compositions for Preparing Nucleic Acid Sequencing Libraries
Application:
18/382,024 →
Publication:
US US20240117343A1
Noninvasive Prenatal Screening Using Dynamic Iterative Depth Optimization
Application:
18/388,650 →
Publication:
US US20240194293A1
Personalized Methods for Detecting Circulating Tumor Dna
Application:
18/410,950 →
Publication:
US US20240150846A1
Cancer Biomarkers
Evaluation and Improvement of Genetic Screening Tests Using Receiver Operating Characteristic Curves
Application:
18/592,076 →
Publication:
US US20240203521A1
Methods, Compositions, and Kits for Determining the Sex of a Fetus
Application:
18/607,329 →
Publication:
US US20240409999A1
Systems and Methods for Identifying and Quantifying Gene Copy Number Variations
Application:
18/638,528 →
Publication:
US US20240352511A1
Electronic Variant Classification
Application:
18/646,644 →
Publication:
US US20240282407A1
Artificial Intelligence Predictive Interactivity Based on Recursive Data Analysis
Systems and Methods for Inferring Genetic Ancestry from Low-Coverage Genomic Data
Application:
18/765,053 →
Publication:
US US20240363195A1
Automated Nucleic Acid Repeat Count Calling Methods
Application:
18/781,847 →
Publication:
US US20250095784A1
Laboratory Execution and Automation Systems
Application:
18/825,981 →
Publication:
US US20250066862A1
Systems and Methods for Automatically Generating Genetic Risk Assessments
Application:
18/887,919 →
Publication:
US US20250013960A1
Methods for Detection and Quantitation of Circulating Tumor Dna
Application:
18/930,324 →
Publication:
US US20250137061A1
Sensitivity of Tumor-Informed Minimal Residual Disease Panels
Application:
18/930,340 →
Publication:
US US20250140346A1
Sensitivity and Estimation of Tumor-Informed Minimal Residual Disease Panels
Application:
18/930,353 →
Publication:
US US20250137038A1
Methods for Improving Minimal Residual Disease Assays
Application:
18/930,793 →
Publication:
US US20250140343A1
Use of Multi-Nucleotide and Structural Variants for Improved Sensitivity and Specificity of Circulating Tumor Dna Assays
Application:
18/930,949 →
Publication:
US US20250137064A1
Combinatorial Dna Screening
Application:
18/932,498 →
Publication:
US US20250122580A1
Personalized Methods of Detecting Circulating Tumor Dna
Patent:
12,545,963 →
Application:
18/965,294 →
Use of Multi-Nucleotide and Structural Variants for Improved Sensitivity and Specificity of Circulating Tumor Dna Assays
Application:
18/972,303 →
Publication:
US US20260117306A1
Methods and Materials for Assessing Homologous Recombination Deficiency
Application:
19/048,611 →
Publication:
US US20250179587A1
Methods and Materials for Assessing Loss of Heterozygosity
Application:
19/087,361 →
Publication:
US US20250215509A1
Methods and Materials for Assessing Loss of Heterozygosity
Application:
19/088,442 →
Publication:
US US20250250643A1
Methods and Materials for Assessing Homologous Recombination Deficiency
Application:
19/088,496 →
Publication:
US US20250223655A1
Rna-Facs for Rare Cell Isolation and Detection of Genetic Variants
Application:
19/112,211 →
Publication:
US US20260092314A1
Methods of Detecting and Enriching Circulating Tumor Dna
Application:
19/231,226 →
Publication:
US US20260022423A1
Signatures for Predicting Cancer Immune Therapy Response
Application:
19/245,180 →
Publication:
US US20260063636A1
Hereditary Cancer Genes
Application:
19/282,486 →
Publication:
US US20260176703A1
Methods of Improved Somatic Mutation Detection
Application:
63/636,066 →
Targeted Depletion Sequencing for Use in Minimum Residual Disease Assays
Application:
63/672,178 →
Combinatorial Variant Detection for Rapid Genotyping
Application:
63/693,014 →
Methods of Classifying Prostate Cancer
Application:
63/695,262 →
Methods and Assays for Extraction-Free Detection of Nucleic Acids in a Biological Sample
Application:
63/742,802 →
Methods for Detection of Maternal Mosaic Aneuploidy in Fetal Aneuploidy Screening
Application:
63/748,849 →
Form
Patent:
764,579 →
Application:
29/487,244 →
Form
Patent:
764,580 →
Application:
29/487,246 →
Form
Patent:
764,581 →
Application:
29/487,249 →
Form
Patent:
730,981 →
Application:
29/487,239 →
DEP2 and Its Uses in Major Depressive Disorder and Other Related Disorders
System and Methods for Detecting Genetic Variation
Methods and Materials for Assessing Allelic Imbalance
High-Throughput Sample Processing Systems and Methods of Use
Methods and Materials for Assessing Loss of Heterozygosity
Methods and Materials for Assessing Allelic Imbalance
High-Throughput Sample Processing Systems and Methods of Use
Cancer Biomarkers
Robotic System for Sorting Sample Tubes
Methods and Materials for Assessing Homologous Recombination Deficiency
Automated Nucleic Acid Repeat Count Calling Methods
Cancer Biomarkers
Cancer Biomarkers
Combinatorial DNA Screening
Methods and Materials for Assessing Loss of Heterozygosity
Methods and Materials for Assessing Allelic Imbalance
Methods and Compositions for Enrichment of Target Polynucleotides
A Method for Treating Cancer
Gene Signatures for Cancer Prognosis
Gene Signatures for Cancer Prognosis
Methods and Compositions for Enrichment of Target Polynucleotides
Reagent Delivery and Waste Management System
High-Throughput Sample Processing Systems and Methods of Use
Hereditary Cancer Genes
Method of Treating Cancer
Methods and Materials for Assessing Allelic Imbalance
Copy Number Variant Caller
Enrichment of Cell-Free Dna from a Biological Sample
Methods and Compositions for Enrichment of Target Polynucleotides
Systems and Methods for Inferring Genetic Ancestry from Low-Coverage Genomic Data
Nucleic Acid Sequencing Adapters and Uses Thereof
Methods and Compositions for Preparing Nucleic Acid Sequencing Libraries
Noninvasive Prenatal Screening Using Dynamic Iterative Depth Optimization
Fetal Sex Determination Using Capillary Blood from Upper Arm
Combinatorial Dna Screening
Devices for Handling Laboratory Plates and Methods of Using the Same
Systems and Methods for Identifying and Quantifying Gene Copy Number Variations
Noninvasive Prenatal Screening Using Dynamic Iterative Depth Optimization with Depth-Scaled Variance Determination
Patent:
12,020,779 →
Application:
16/124,033 →
Combinatorial Dna Screening
Systems and Methods for Inferring Genetic Ancestry from Low-Coverage Genomic Data
Automated Nucleic Acid Repeat Count Calling Methods
Personalized Methods for Detecting Circulating Tumor Dna
Alert Rule System and Method for Updating Alert Rules
Automated Methods of Detecting Cell Free Dna
Methods of Preparing a Dna Fraction Enriched with Circulating Tumor Dna
Methods and Materials for Assessing Homologous Recombination Deficiency
Reagent Delivery and Waste Management System
Methods of Detecting Dna in a Sample
Automated Methods of Detecting Cell Free Dna
Enrichment of Circulating Tumor Dna
Methods of Detecting and Enriching Circulating Tumor Dna
Multiple-Ancestry Polygenic Risk Assessment for Breast Cancer
PCT:
PCT/US2024/036902 ↗
Rna-Facs for Rare Cell Isolation and Detection of Genetic Variants
PCT:
PCT/US2023/026851 ↗
Targeted Depletion Sequencing for Use in Minimum Residual Disease Assays
PCT:
PCT/US2025/037594 ↗
Improved Sensitivity and Estimation of Tumor-Informed Minimal Residual Disease Panels
PCT:
PCT/US2024/053393 ↗
Improved Sensitivity of Tumor-Informed Minimal Residual Disease Panels
PCT:
PCT/US2024/053386 ↗
Methods for Detection and Quantitation of Circulating Tumor Dna
PCT:
PCT/US2024/053380 ↗
Use of Multi-Nucleotide and Structural Variants for Improved Sensitivity and Specificity of Circulating Tumor Dna Assays
PCT:
PCT/US2024/053468 ↗
Methods for Improving Minimal Residual Disease Assays
PCT:
PCT/US2024/053451 ↗
Method of Predicting the Absolute Risk Reduction from Androgen Deprivation Therapy Added to Radiation Therapy in Patients with Prostate Cancer
PCT:
PCT/US2024/030876 ↗
Methods of Improved Somatic Mutation Detection
PCT:
PCT/US2025/025011 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 27, 2016
From: MYRIAD GENETICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 041198/0578 →
Assignment of Assignor's Interest
Jun 5, 2017
From: HAQUE, IMRAN SAEEDUL; MAGUIRE, JARED ROBERT; CHU, CLEMENT; EVANS, ERIC ANDREW
To: COUNSYL, INC.
Reel/Frame 042602/0685 →
Patent Security Agreement
Nov 3, 2017
From: COUNSYL, INC.
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 044364/0851 →
Release of Security Interest
Jul 31, 2018
From: PERCEPTIVE CREDIT HOLDINGS, LP
To: COUNSYL, INC.
Reel/Frame 046676/0110 →
Change of Name
Sep 24, 2018
From: COUNSYL, INC.
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 047140/0334 →
Security Interest
Sep 15, 2020
From: MYRIAD WOMEN'S HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 053773/0968 →
Assignment of Assignor's Interest
Feb 19, 2021
From: HONG, SUN; BEAUCHAMP, KYLE; HAAS, KEVIN
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 055343/0563 →
Assignment of Assignor's Interest
Feb 25, 2021
From: STONE, STEVEN; GUTIN, ALEXANDER; WAGNER, SUSANNE; REID, JULIA
To: MYRIAD GENETICS, INC.
Reel/Frame 055417/0737 →
Assignment of Assignor's Interest
Mar 30, 2021
From: HAAS, KEVIN R.; HONG, SUN HAE; KALETA, PIOTR; HOGAN, GREGORY JOHN
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 055774/0324 →
Assignment of Assignor's Interest
Oct 11, 2021
From: ZHARKIKH, ANDREY; TIMMS, KIRSTEN; PERRY, MICHAEL; GUTIN, ALEXANDER
To: MYRIAD GENETICS, INC.
Reel/Frame 057751/0611 →
Assignment of Assignor's Interest
Oct 18, 2021
From: ABKEVICH, VICTOR; GUTIN, ALEXANDER; TIMMS, KIRSTEN; LANCHBURY, JERRY
To: MYRIAD GENETICS, INC.
Reel/Frame 057818/0063 →
Assignment of Assignor's Interest
Oct 18, 2021
From: TIMMS, KIRSTEN; ALLEN, BRIAN; HARTMAN, ANNE-RENEE
To: MYRIAD GENETICS, INC.
Reel/Frame 057818/0744 →
Assignment of Assignor's Interest
Oct 21, 2021
From: GUTIN, ALEXANDER; TIMMS, KIRSTEN; LANCHBURY, JERRY
To: MYRIAD GENETICS, INC.
Reel/Frame 057864/0069 →
Assignment of Assignor's Interest
Oct 27, 2021
From: ABKEVICH, VICTOR; TIMMS, KIRSTEN; GUTIN, ALEXANDER
To: MYRIAD GENETICS, INC.
Reel/Frame 057930/0617 →
Assignment of Assignor's Interest
Nov 1, 2021
From: REID, JULIA
To: MYRIAD GENETICS, INC.
Reel/Frame 057981/0446 →
Assignment of Assignor's Interest
Nov 1, 2021
From: ABKEVICH, VICTOR; TIMMS, KIRSTEN; GUTIN, ALEXANDER
To: MYRIAD GENETICS, INC.
Reel/Frame 057981/0389 →
Assignment of Assignor's Interest
Apr 13, 2022
From: HUGHES, ELISHA; GUTIN, ALEXANDER
To: MYRIAD GENETICS, INC.
Reel/Frame 059589/0225 →
Assignment of Assignor's Interest
Apr 13, 2022
From: ABKEVICH, VICTOR; GUTIN, ALEXANDER; TIMMS, KIRSTEN; LANCHBURY, JERRY
To: MYRIAD GENETICS, INC.
Reel/Frame 059589/0520 →
Assignment of Assignor's Interest
Apr 14, 2022
From: STONE, STEVEN; GUTIN, ALEXANDER; WAGNER, SUSANNE; REID, JULIA
To: INC., MYRIAD GENETICS
Reel/Frame 059600/0428 →
Assignment of Assignor's Interest
Apr 19, 2023
From: BEAUCHAMP, KYLE; MUZZEY, DALE; GANESH, ADITHYA C.; HONG, SUN HAE
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 063383/0384 →
Assignment of Assignor's Interest
May 26, 2023
From: MYRIAD GENETICS, INC.
To: MYRIAD GENETICS, INC.; THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 063778/0231 →
Assignment of Assignor's Interest
Jun 29, 2023
From: HAAS, KEVIN R.; WANG, XIN; GRAUMAN, PETER V.
To: COUNSYL, INC.
Reel/Frame 064163/0741 →
Change of Name
Jun 29, 2023
From: COUNSYL, INC.
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064163/0629 →
Change of Name
Jun 29, 2023
From: COUNSYL, INC.
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064163/0008 →
Change of Name
Jun 29, 2023
From: COUNSYL, INC.
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064162/0688 →